Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma

Daren Austin (Uxbridge, United Kingdom), Daren Austin, Isabelle Pouliquen, Oliver Keene, Steve Yancey

Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Session: Pharmacological intervention in humans and murine models of asthma
Session type: Thematic Poster
Number: 1110
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daren Austin (Uxbridge, United Kingdom), Daren Austin, Isabelle Pouliquen, Oliver Keene, Steve Yancey. Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma. Eur Respir J 2016; 48: Suppl. 60, 1110

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Effect of baseline eosinophil count on response to CYT003-QbG10 in patients with persistent allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Benralizumab effect on blood basophil counts in adults with uncontrolled asthma
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Induced sputum supernatant eicosanoids during oral aspirin challenge of asthmatic patients with and without aspirin hypersensitivity and healthy controls
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Total and free IgE in evolution of severe asthma after omalizumab treatment
Source: International Congress 2016 – Asthma management
Year: 2016